US Trustee Says Solar Biotech Sale Price May Be Too Low
The U.S. Trustee's Office has filed an objection in Delaware bankruptcy court to Solar Biotech's proposed $14.9 million credit bid asset sale, saying it does not appear to leave anything to...To view the full article, register now.
Already a subscriber? Click here to view full article